RAS in Pregnancy and Preeclampsia and Eclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Neurology

Background:

• Preeclampsia is a common pregnancy complication marked by hypertension and multi-organ dysfunction, linked to endothelial dysfunction.
• The precise etiology of preeclampsia remains unclear, but the renin-angiotensin system (RAS) is implicated in its multisystemic effects.
• Endothelial dysfunction is a key feature, contributing to the widespread organ damage observed in preeclampsia.

Purpose of the Study:

• To review existing evidence on the role of the renin-angiotensin system (RAS) in the development of preeclampsia.
• To identify specific components of the RAS involved in triggering preeclampsia.
• To elucidate the mechanisms by which RAS activation leads to brain involvement in preeclampsia.

Main Methods:

• Literature review of studies investigating the renin-angiotensin system (RAS) and preeclampsia.
• Analysis of research on the molecular components and pathways of the RAS.
• Synthesis of findings related to RAS and its impact on various organs, particularly the brain.

Main Results:

• Evidence suggests a significant role for the renin-angiotensin system (RAS) in the pathogenesis of preeclampsia.
• Specific components and alterations within the RAS are identified as potential triggers for the disease.
• Mechanisms linking RAS overactivity to endothelial dysfunction and subsequent brain engagement are discussed.

Conclusions:

• The renin-angiotensin system (RAS) is strongly implicated in the initiation and progression of preeclampsia.
• Understanding RAS involvement offers potential therapeutic targets for managing preeclampsia and its neurological complications.
• Further research into RAS modulation may provide novel strategies for preventing and treating this pregnancy disorder.